Fluorescein application in spinal ependymomas: have we come so far?
Neurosurg Rev
.
2022 Oct;45(5):3467-3468.
doi: 10.1007/s10143-022-01821-4.
Epub 2022 May 31.
Authors
Lucas Serra Sant'Anna
1
,
Raphael Sepúlvida
1
,
Rafael Abbud
1
,
Rafael Teixeira Magalhães Leal
1
,
Marcus André Acioly
2
3
Affiliations
1
Division of Neurosurgery, Fluminense Federal University, Niterói, Rio de Janeiro, Brazil.
2
Division of Neurosurgery, Fluminense Federal University, Niterói, Rio de Janeiro, Brazil. marcusacioly@yahoo.com.br.
3
Division of Neurosurgery, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil. marcusacioly@yahoo.com.br.
PMID:
35641841
DOI:
10.1007/s10143-022-01821-4
No abstract available
Publication types
Letter
Comment
MeSH terms
Ependymoma* / surgery
Fluorescein
Humans
Spinal Cord Neoplasms* / surgery
Spine
Substances
Fluorescein